Drug Shortage Assistance Award

As part of FDA’s work to prevent and mitigate drug shortages, the Agency has created the FDA Drug Shortage Assistance Award to provide public recognition to drug companies and manufacturers who have demonstrated a commitment to preventing or alleviating drug shortages of medically necessary drugs. This award recognizes efforts of drug companies and manufacturers who have worked in cooperation with FDA and have implemented strategies to help provide a steady supply of medically necessary drugs for patients at a time when critical drug shortages pose a challenge for health care providers and patients nationwide, while maintaining a commitment to quality manufacturing.

CompanyFDA Letter
Fresenius Kabi USA, LLCAward Letter(PDF - 352 KB
TevaAward Letter (PDF - 352 KB
ADIENNE Pharma & BiotechAward Letter (PDF - 76 KB)
Eurohealth International Sàrl, a subsidiary of Hikma PharmaceuticalsAward Letter (PDF - 29 KB)
Clinigen Group plcAward Letter (PDF - 32 KB)
Guerbet GroupAward Letter (PDF - 32 KB)


Page Last Updated: 10/25/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English